On December 17, 2021, Scopus BioPharma Inc. mailed a letter to its stockholders in connection with the Company’s annual meeting of stockholders that will be reconvened on December 20, 2021. Further, the Company encouraged its shareholders to vote for the re-election of its director nominees, Raphael (Rafi) Hofstein and David S. Battleman, at the Company’s annual shareholders meeting.